|
Match
|
Document |
Document Title |
|
|
US20090269401 |
Controlled Release Solid Preparation
Disclosed is a solid preparation which comprises at least one active ingredient and at least one dissolution-controlling base substance and can be formed by compression molding, wherein the...
|
|
|
US20090269399 |
PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the...
|
|
|
US20090263480 |
TASTE-MASKED PHARMACEUTICAL COMPOSITIONS PREPARED BY COACERVATION
There is provided a method for preparing an orally disintegrating tablet (ODT) composition comprising microparticles of one or more taste-masked active pharmaceutical ingredients,...
|
|
|
US20090263476 |
Composition of Rapid Disintegrating Direct Compression Buccal Tablet
A composition of a rapidly disintegrating buccal dosage form containing a drug, at least one non-effervescent base such as an alkali metal or alkaline earth metal oxide or hydroxide, and a...
|
|
|
US20090252790 |
TABLET FORMULATION
The present invention relates to a pharmaceutical fixed dose combination tablet comprising repaglinide and metformin. The present invention also provides a method of producing said tablet.
|
|
|
US20090252787 |
GRANULAR PHARMACEUTICAL COMPOSITIONS
Pharmaceutical compositions comprising a plurality of formulated particles containing at least one active ingredient and at least one pharmaceutically acceptable excipient, granulated with a...
|
|
|
US20090246276 |
Pharmaceutical Compositions
The present invention relates to a pharmaceutical composition comprising a tablet core comprising a combination of actives selected from the group consisting of bupropion hydrochloride and...
|
|
|
US20090232889 |
CRYSTALLINE SALTS OF QUINOLINE COMPOUNDS AND METHODS FOR PREPARING THEM
A stable solid pharmaceutical composition consisting essentially of an effective amount of a crystalline salt of formula (II)
together with an alkaline-reacting component maintaining the pH...
|
|
|
US20090232858 |
METHOD AND PROCESS FOR THE PRODUCTION OF MULTI-COATED RECOGNITIVE AND RELEASING SYSTEMS
The present invention includes compositions, methods, systems for the controlled delivery of an active agent in a tablet polymer comprising two or more layers, wherein each of the two or more...
|
|
|
US20090226516 |
SARTAN COMPOSITIONS
The invention provides a sartan or salt thereof composition having a dissolution in acetate buffer at pH 4.0 using USP type I method basket 10 Mesh at 75 rpm, of at least 20% after 90 minutes, 50%...
|
|
|
US20090226515 |
STATIN COMPOSITIONS
The present invention relates to an improved statin or salt thereof composition, especially an atorvastatin composition, which exhibits enhanced dissolution properties in acidic media. It comprises...
|
|
|
US20090226512 |
Methods and Compositions for Oral Delivery of FTS
Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and...
|
|
|
US20090226510 |
PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN
A unit dosage form comprising atorvastatin or a pharmaceutically acceptable salt thereof, prepared without a granulation step, wherein the measured atorvastatin potency of said dosage form shows a...
|
|
|
US20090220594 |
Tablet of Paracetamol Containing an Encapsulated Flavorant
A medicament tablet containing paracetamol (acetaminophen) as the (or an) active ingredient, and an encapsulated flavorant. The tablet may be swallowed in tablet form or may be dissolved or...
|
|
|
US20090214640 |
DELAYED RELEASE PHARMACEUTICAL ORAL DOSAGE FORM AND METHOD OF MAKING SAME
The present invention relates to a delayed release pharmaceutical oral dosage form and method of making same. The delayed release dosage form comprises one or more active ingredients within a...
|
|
|
US20090208571 |
Dosage form containing pantoprazole as active ingredient
Dosage forms for the oral administration of the magnesium salt of pantoprazole are described.
|
|
|
US20090203621 |
Tripeptides that Down Regulate the Activity of Plasma Membrane transporters Including Sodium-D-Glucose Cotransporter Sglt1
The present invention relates to the use of a regulatory protein RS1 fragment or a nucleic acid molecule encoding said regulatory protein RS1 fragment for the preparation of a pharmaceutical...
|
|
|
US20090202617 |
Gas based wound and tissue therapeutics
This invention provides articles of manufacture and bandages comprising compartments and layers comprising oxygen and other therapeutic gas storage forms and perfluorocarbons. This invention also...
|
|
|
US20090196922 |
BILAYER TABLET FOR PREVENTING CARDIOVASCULAR EVENTS
The present invention relates to a bilayer tablet which comprises a compartment containing a pharmaceutically acceptable simvastatin compound as its active ingredient; and at the same time a...
|
|
|
US20090196919 |
OXCARBAZEPINE DOSAGE FORMS
The present invention relates to dosage forms of oxcarbazepine for oral administration that contain oxcarbazepine having a median particle size of from about 14 μm to about 30 μm and to processes...
|
|
|
US20090186084 |
FORM OF ADMINISTRATION OF RACECADOTRIL
The present invention relates to a new racecadotril formulation in the form of tablets, the preparation process thereof and the use thereof to treat diarrhoea.
|
|
|
US20090181084 |
Oral fast-disintegrating tablet including particles of slowly-releaseable ascorbic acid
An oral fast-disintegrating tablet includes many tiny particles of slowly-releasable ascorbic acid, and a fast-disintegrating ingredient mixed with the many tiny particles that are dispersedly...
|
|
|
US20090181083 |
Porous tablets as carriers for liquid formulations
A novel tablet product that in an easy, flexible and reproducible manner can be loaded with a relatively high amount of a pharmaceutically acceptable liquid formulation e.g. carrying a...
|
|
|
US20090175937 |
Misuse Preventative, Controlled Release Formulation
Disclosed is a misuse preventative, controlled release formulation comprising a core comprising a superabsorbent material (for example, polycarbophil), a controlled release coat surrounding the...
|
|
|
US20090162432 |
Stable laquinimod preparations
The subject invention provides a pharmaceutical composition comprising N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-
oxoquinoline-3-carboxamide or the salt thereof; a...
|
|
|
US20090148522 |
HEATED ROLLER COMPACTION PROCESS FOR MAKING PHARMACEUTICAL COMPOSITIONS
A process for using a heated roller compactor to prepare melt granulated composition of a therapeutic compound, especially a poorly compressible and/or moisture sensitive therapeutic compound, with...
|
|
|
US20090142395 |
DEFERASIROX PHARMACEUTICAL COMPOSITIONS
The present invention provides a process of preparing a high-load formulation of deferasirox with a sufficiently high dissolution rate and good bioavailability, which reduces the effect of the...
|
|
|
US20090142394 |
Gastric Antacid
A novel particulate composite hydrotalcite which offers antacidic effect comparable to that of a particulate hydrotalcite so far used as a gastric antacid and, further, offers excellent stomach...
|
|
|
US20090136571 |
PHARMACEUTICAL FORMULATIONS CONTAINING IRBESARTAN
The present invention relates to pharmaceutical compositions and formulations for the oral administration of Irbesartan, one of its pharmaceutically acceptable salts or its polymorphs, optionally...
|
|
|
US20090136570 |
Taste-Masked Tablets and Granules
Orally administered, taste-masked tablets and granules contain (a) a hydroxypyrimidinone carboxamide, a hydroxy-tetrahydropyridopyrimidinone carboxamide, or a related carboxamide compound, or a...
|
|
|
US20090117183 |
ORAL CONTRACEPTIVE CONTAINING A GESTAGEN AND AN ESTROGEN COMBINED WITH PHARMACEUTICALLY ACCEPTABLE AUXILIARY AGENTS AND/OR EXCIPIENTS, BUT NOT CONTAINING LACTOSE, AND METHOD OF MAKING SAME
The method produces a lactose-free oral contraceptive composition containing a combination of a gestagen and an estrogen together with one or more pharmaceutically acceptable auxiliary agents...
|
|
|
US20090110725 |
SOLID, ORODISPERSIBLE AND/OR DISPERSIBLE COMPOSITION, WITHOUT AN EXCIPIENT OF KNOWN EFFECT AND ITS PROCESS OF PREPARATION
The present invention relates to a solid, orodispersible and/or dispersible composition comprising (a) from 0.1 to 59% by weight of at least one active substance with particle size not exceeding 50...
|
|
|
US20090110722 |
Composition
A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also...
|
|
|
US20090098200 |
COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION
Compositions are provided comprising a lipophilic active compound, e.g., a human or veterinary drug or a nutraceutical, interwoven with a polymeric matrix formed by two or more polymers, wherein...
|
|
|
US20090092669 |
STABLE IMATINIB COMPOSITIONS
Formulations containing imatinib, preferably imatinib mesylate, with high polymorphic stability and the processes for the preparation thereof are disclosed.
|
|
|
US20090087486 |
Foam Wafer Containing a Polyvinyl Alcohol-Polyethyleneglycol-Graft Copolymer
Sheet-like dosage forms dissolving or disintegrating in an aqueous medium for releasing at least one active substance in a body orifice or body cavity. The sheet-like dosage forms comprise a...
|
|
|
US20090081289 |
PLANT AND A PROCESS FOR PRODUCTION OF TABLETS
The invention relates to a plant for production of tablets, a process for production of tablets and tablets as such. The plant comprises a mixing device producing a mixed liquid feed of active...
|
|
|
US20090074862 |
LOW-DOSE DOXEPIN FORMULATIONS AND METHODS OF MAKING AND USING THE SAME
The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
|
|
|
US20090074861 |
STABLE TABLET CONTAINING DROXIDOPA
A tablet containing droxidopa as an active ingredient in a proportion of 20-80 wt % relative to the total weight of the tablet, and characteristically containing at least one excipient selected...
|
|
|
US20090060996 |
Formulations of Clopidogrel Bisulphate
This invention relates to pharmaceutical tablet formulations of clopidogrel bisulphate which include glyceryl dibehenate as lubricant. The tablets are found to be very stable and to exhibit...
|
|
|
US20090060995 |
Dispersible sustained release pharmaceutical compositions
Disclosed herein are pharmaceutical compositions, in particular, dispersible compositions comprising sustained release granules of at least one active pharmaceutical ingredient and at least one...
|
|
|
US20090053309 |
ADHESIVE COMPOSITIONS FOR THE TREATMENT OF XEROSTOMIA
Compositions and methods for the treatment of xerostomia are disclosed herein. Methods for making the compositions are also disclosed herein. The compositions are designed for individuals having...
|
|
|
US20090041841 |
CONTROLLED RELEASE TABLET FORMULATIONS FOR THE PREVENTION OF ARRHYTHMIAS
Methods, formulations, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias, including the treatment or prevention of atrial fibrillation are disclosed....
|
|
|
US20090041838 |
Anti-Misuse Microparticulate Oral Drug Form
The invention relates to solid microparticulate oral dosage forms having a composition that prevents the misuse of the active pharmaceutical ingredient (API) contained therein. The aim of the...
|
|
|
US20090041829 |
PHARMACEUTICAL DOSAGE FORMS COMPRISING A LIPID PHASE
A tablet for oral administration comprises a lipid phase, comprised to 80% by weight or more by a mixture of (a) triglyceride, (b) mono- or/and diglyceride, and (c) cell membrane lipid; (d) one or...
|
|
|
US20090035368 |
EMBEDDED MICELLAR NANOPARTICLES
The present invention relates to a thermostable solid composition containing nanosized micelles, the micelles containing a poorly soluble chemical substance, such as a biologically active...
|
|
|
US20090028935 |
CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF
Disclosed are amorphous carvedilol salt forms, controlled-release carvedilol compositions, and methods of preparing the forms and compositions.
|
|
|
US20090022795 |
Stable Pharmaceutical Formulation of an Acid Labile Compound and Process for Preparing the Same
The disclosed invention provides oral pharmaceutical formulations of an acid labile benzimidazole derivative comprising (a) a core comprising an acid labile benzimidazole derivative, (b) a seal...
|
|
|
US20090022794 |
Topiramate Tablet Formulation
The invention provides pharmaceutical compositions comprising as active ingredient topiramate, which are suitable for manufacturing tablet formulations by direct compression. The compositions...
|
|
|
US20090017114 |
Tranexamic acid formulations with reduced adverse effects
Tranexamic acid formulated in an oral dosage form with at least one agent that decreases tranexamic acid release in the stomach. Such formulations minimize nausea, vomiting, and other adverse...
|